Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
March 22 2022 - 12:50PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
For the month of March 2022
Commission file number: 001-32749
FRESENIUS MEDICAL CARE AG & Co. KGaA
(Translation of registrant's name into English)
Else-Kröner Strasse 1
61346 Bad Homburg
Germany
(Address of principal executive offices)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if
the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
EXHIBITS
The following exhibits are being furnished with
this Report:
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
DATE: March 22, 2022
|
Fresenius
Medical Care AG & Co. KGaA, |
|
a partnership limited by shares, represented
by: |
|
|
|
Fresenius
medical care management ag, its |
|
General Partner |
|
By: |
/s/ Rice Powell |
|
|
Name: |
Rice Powell |
|
|
Title: |
Chief Executive Officer and Chairman of the Management Board of the General Partner |
|
|
|
|
|
By: |
/s/ Helen Giza |
|
|
Name: |
Helen Giza |
|
|
Title: |
Chief Financial Officer and Member of the Management Board of the General Partner |
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Jul 2023 to Jul 2024